Many studies have shown that high TMB in cancer is associated with a better prognosis (56, 57), which may be because tumor cells in patients with high TMB express more immunogens that are recognized by immune T cells and because anti-PD-1/PD-L1 treatment has a better effect in these patients. The gene discussed is CD274; the disease is cancer.